Skip to main content
. 2022 Apr 16;14:100263. doi: 10.1016/j.mtbio.2022.100263

Table 3.

Summary of examples of meta-surface and nanoarray based plasmonic biosensors.

Surface form Synthesis method System/Method Disease detected Biomarker POC ability Limit of detection Ref.
Meta-substrate Commercial product (Au), magnetic sputtering method Plasmonic fluorescence Cardiac disease Cardiac troponin I High 0.01 ​ng/mL [168]
Commercial product (Au) SPR TB DIG High 63 ​pg/mL [169]
Meta-coated slides Sputtering (Au) SPR Dengue DENV-2 E-proteins Low 0.08 pM [170]
Seed-mediated growth on glass slide (Au) Plasmonic fluorescence Diabetes Islet cell–targeting autoantibodies High N/A [171]
Commercial product (Au) SPR Cardiac disease Cardiovascular autoantibodies Medium N/A [172]
Thermal annealing (Ag) LSPR Dengue Dengue NS1 antigen High 9 nm/(μg/mL) [173]
Evaporation (Au) SPR Cancer Carcinoembryonic antigen High 5 ​ng/mL [174]
Electron beam evaporation, thermal annealing LSPR Liver cancer Liver antigen, liver antibody High Antigen 45.24 ​ng/mL
Antibody
25 ​ng/mL
[175]
Coating Au on butterfly wings SERS Malaria Malarial hemozoin Low N/A [176]
Nanoarray Tetrahedron DNA monomers SPR HIV HIV-related DNA High 48 ​fM [177]
Commercial product (Spreeta 2000 chip) SPR TB Ag85 High 10 ​ng/mL [178]
Commercial product (Au) SPR Ebola mAb1, mAb2, mAb3 Medium 0.5 ​pg/mL [179]
Seed-mediated growth on glass slide (Au) SPR Diabetes ZnT8A Low N/A [180]